Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by LTOWNER


T.TRL.WT.A

BLACKOUT

I am somewhat intrigued that Trimel officers and directors are currently in a...

April 16, 2014

T.TRL.WT.A

RE:RE:RE:RE:RE:New Trimel website

Wixard re: "the anxiety medication sounds like a perfect fit for us"...

April 7, 2014

T.TRL.WT.A

RE:RE:RE:RE:CV risk study is "sloppy"

If 50% of the population is going to be prescribed Statins then we are all...

April 3, 2014

T.TRL.WT.A

RE:RE:CV risk study is "sloppy"

Heaven help us if the statin comment is correct.  I just finished...

April 2, 2014

T.TRL.WT.A

Negative Study: Gross Data Mismanagement

Great reading today guys/gals.  One has to love the quality of posts on...

April 2, 2014

T.TRL.WT.A

RE:RE:RE:Options

Option info was filed March 13 & March 14 (for Tom Rossi) but the filings...

March 19, 2014

T.TRL.WT.A

Is He Done Yet??

1,517,000 cross at $0.65 by GMO 11:20 ET

March 19, 2014

T.TRL.WT.A

RE:Nathan Bryson

PharmaZ could be on to something.   We know that the strategy of...

March 18, 2014

T.TRL.WT.A

Insider Trades/The Melnyk Connection

On Balance insider trading in the last three months is hugely positive in...

March 16, 2014

T.TRL.WT.A

RE:RE:RE:RE:RE:RE:RE:RE:RE:Melnyk Not Helping the Cause

Melnyk news now on Sedar, cannot find Option filing yet.

March 14, 2014

T.TRL.WT.A

RE:RE:RE:RE:RE:RE:RE:RE:Melnyk Not Helping the Cause

PR re Melnyk sent out of StockWatch at 9:07 PM ET last night.  Since the...

March 14, 2014

T.TRL.WT.A

RE:RE:RE:RE:RE:Melnyk Not Helping the Cause

Thanks BioGrowth.  It may provide a clue as to what Melnyk may be...

March 14, 2014

T.TRL.WT.A

RE:RE:Melnyk Not Helping the Cause

Feb 26 TRL opened @ .86, reached a high of .89, a low of .76 & closed at ...

March 14, 2014

T.TRL.WT.A

RE:Melnyk Not Helping the Cause

After the sale, Melnyk will hold 37,110,783 shares or 22.75%; ...

March 14, 2014

T.TRL.WT.A

Melnyk Not Helping the Cause

"Trimel Pharmaceuticals Corp. shareholder Eugene Melnyk has filed a...

March 14, 2014

T.TRL.WT.A

RE:Big Os and small Bs

Interesting.  Always nice to have more than one use for a drug. ...

March 12, 2014

T.TRL.WT.A

Short Position Feb. 28

Still miniscule - pretty risky to bet against FDA Approval & Tefina...

March 11, 2014

T.TRL.WT.A

FDA’s Willingness To Approve Another TRT Drug

AVEED’s approval last Thursday answers the question as to whether the FDA is...

March 9, 2014

T.TRL.WT.A

My CC Notes: Rossi "Very Very Excited"

CEO Rossi concluded the conference call by saying management is “very very...

March 9, 2014

T.TRL.WT.A

RE:RE:BNN

Melnyk is selling 550,000 and keeping over 38 million shares.  That'...

February 25, 2014

Featured Company